References
- Melen I. Chronic sinusitis: clinical and pathophysiological aspects. Acta Otolaryngol 1994; 515: 45–8
- Scheid DC, Hamm RM. Acute bacterial rhinosinusitis in adults, part II: Treatment. Am Fam Physician 2004; 70: 1697–704
- Cable BB, Wassmuth Z, Mann EA, Hommer D, Connely G, Klem C, et al. The effect of corticosteroids in the treatment of experimental sinusitis. Am J Rhinol 2000; 14: 217–22
- Aukema AA, Fokkens WJ. Chronic rhinosinusitis: management for optimal outcomes. Treat Respir Med 2004; 3: 97–105
- Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA 2001; 286: 3097–105
- Sütbeyaz Y, Aktan B, Yoruk O, Özdemir H, Gundogdu C. Treatment of sinusitis with corticosteroids in combination with antibiotics in experimentally induced rhinosinusitis. Ann Otol Rhinol Laryngol 2008; 117: 389–94
- Norlander T, Westrin KM, Stierna P. The inflammatory response of the sinus and nasal mucosa during sinusitis: implications for research and therapy. Acta Otolaryngol Suppl 1994; 515: 38–44
- Brook I. Sinusitis – overcoming bacterial resistance. Int J Pediatr Otorhinolaryngol 2002; 58: 27–36
- Norlander T, Kwon SH, Henriksson G, Westrin KM, Sandstedt K, Stierna P. Effect of systemic pretreatment with betamethasone on the bacterial flora, inflammatory response, and polyp formation in experimentally infected rabbit maxillary sinus mucosa. Laryngoscope 1998; 108: 411–17
- Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993; 45: 3–7
- Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 2000; 14: 367–73
- Westerveld GJ, Dekker I, Voss HP, Bast A, Scheeren RA. Antioxidant levels in the nasal mucosa of patients with chronic sinusitis and healthy controls. Arch Otolaryngol Head Neck Surg 1997; 123: 201–4
- Unal M, Tamer L, Pata YS, Kilic S, Degirmenci U, Akbas Y, et al. Serum levels of antioxidant vitamins, copper, zinc and magnesium in children with chronic rhinosinusitis. J Trace Elem Med Biol 2004; 18: 189–92
- Kaygusuz I, Ilhan N, Karlidag T, Keles E, Yalcin S, Cetiner H. Free radicals and scavenging enzymes in chronic tonsillitis. Otolaryngol Head Neck Surg 2003; 129: 265–8
- Kouno T, Egashira T, Takayama F, Kudo Y, Yamanaka Y. Effect of methylprednisolone on plasma lipid peroxidation induced by lipopolysaccharide. Jpn J Pharmacol 1994; 64: 163–9
- Friedman AD, Shah JB, Takoudes TG, Haddad J. The role of free radicals in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2002; 128: 1055–7
- Kang MY, Tsuchiya M, Packer L, Manabe M. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998; 42: 4–12
- Davies KJ. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000; 50: 279–89
- Testa B, Mesolella M, Testa D, Giuliano A, Costa G, Maione F, et al. Glutathione in the upper respiratory-tract. Ann Otol Rhinol Laryngol 1995; 104: 117–19
- Koç R., Akdemir KH, Karakucuk EI, Oktem IS, Menku A. Effect of methylprednisolone, tirilazad mesylate and Vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 1999; 37: 29–32